Home › Research › Disparities
Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US
Ehrlich JR, Goldstein J, Swenor BK, Whitson H, Langa KM, Veliz P.. JAMA neurology, 2022-06-01
Topic: Risk, prevention and care in population studies
Plain-language summary
The number of older adults with dementia in the US and globally is projected to increase as a result of population aging and growth. Main outcomes and measures The estimated population attributable fractions (PAFs) of dementia associated with vision impairment and other dementia risk factors were calculated. Results The probability sample from the Health and Retirement Study included 16 690 participants (weighted demographic characteristics: 54.0% female, 52.0% age ≥65, 10.6% Black, 80% White, and 9.2% identified as other [including American Indian or Alaska Native, Asian, and Hawiian Native or Pacific Islander, although specific data were not available]). The 12 dementia risk factors in the PAF model were associated with an estimated 62.4% of dementia cases in the US. The PAF of vision impairment was 1.8%, suggesting that more than 100 000 prevalent dementia cases in the US could potentially have been prevented through healthy vision.
What this study adds
Evidence grade: Low
This is a cross-sectional study of 16 participants. This study calculated that vision impairment had a population attributable fraction of 1.8% for dementia, suggesting more than 100,000 prevalent dementia cases in the US could potentially have been prevented through healthy vision. Reported effect size: 54.0%; 52.0%; 10.6%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ehrlich, JR., Goldstein, J., Swenor, B. K., Whitson, H., Langa, K. M., & Veliz, P. (2022). Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US. JAMA neurology. https://doi.org/10.1001/jamaneurol.2022.0723
Vancouver
Ehrlich JR, Goldstein J, Swenor BK, Whitson H, Langa KM, Veliz P. Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US. JAMA neurology. 2022. doi:10.1001/jamaneurol.2022.0723. PMID: 35467745.
BibTeX
@article{ehrlich2022-35467745,
author = {Ehrlich, JR. and Goldstein, J. and Swenor, B. K. and Whitson, H. and Langa, K. M. and Veliz, P.},
title = {{Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US}},
journal = {JAMA neurology},
year = {2022},
doi = {10.1001/jamaneurol.2022.0723},
pmid = {35467745},
url = {https://doi.org/10.1001/jamaneurol.2022.0723}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The number of older adults with dementia in the US and globally is projected to increase as a result of population aging and growth.
- Main outcomes and measures The estimated population attributable fractions (PAFs) of dementia associated with vision impairment and other dementia risk factors were calculated.
- Results The probability sample from the Health and Retirement Study included 16 690 participants (weighted demographic characteristics: 54.0% female, 52.0% age ≥65, 10.6% Black, 80% White, and 9.2% identified as other [including American Indian or Alaska Native, Asian, and Hawiian Native or Pacific Islander, although specific data were not available]).
- The 12 dementia risk factors in the PAF model were associated with an estimated 62.4% of dementia cases in the US.
- The PAF of vision impairment was 1.8%, suggesting that more than 100 000 prevalent dementia cases in the US could potentially have been prevented through healthy vision.
Why it matters
This study calculated that vision impairment had a population attributable fraction of 1.8% for dementia, suggesting more than 100,000 prevalent dementia cases in the US could potentially have been prevented through healthy vision. It is a cross-sectional estimate of modifiable risk factors and does not test any treatment or cure.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Study designcross-sectional
- Participants16
- Effect size54.0%; 52.0%; 10.6%
- Evidence strengthLow
How this study scored 58/100
Published in a leading specialty journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA neurology) |
| Journal's citation record | 2 / 4 | JAMA Neurology: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 1 / 4 | 16 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 68 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 11.3 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 4 / 6 | Cited 8.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 6 other studies in this library |
| Still being cited | 2 / 4 | Cited 48 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Philip Todd Veliz: h-index 40 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35467745) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 58 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamaneurol.2022.0723
- PubMed: 35467745
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
6 studies in the alzhub library list this one in their references.
Related studies in Disparities from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.